 REDWOOD CITY, Calif., June 28, 2021 GLOBE NEWSWIRE -- Rezolute, Inc. Nasdaq: RZLT, a clinical-stage biopharmaceutical company developing transformative therapies for metabolic diseases related to chronic glucose imbalance, has been added to the Russell Microcap Index at the conclusion of the 2021 Russell indexes annual reconstitution, effective after the US market opens on June 28. 